Work

Association of enfortumab vedotin (EV) toxicity with baseline parameters and clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC).

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.e16585

Authors: Karl Semaan, Talal El Zarif, Renee Maria Saliby, Marc Eid, Eddy Saad, Chris Labaki, Lucia Kwak, Marina D. Kaymakcalan, Sylvan Baca, Stephanie A. Berg, Wanling Xie, Charlene Mantia, Toni K. Choueiri, Bradley Alexander McGregor, Joaquim Bellmunt

Institutions: Dana-Farber Cancer Institute, Harvard University

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379335697

Cites:

Cited by: 1

Related to: 10